Dickinson Andrew D: insider trades.
Dickinson Andrew D reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($1.2M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Dickinson Andrew D
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Gilead Sciences, Inc. (GILD) | Officer · Chief Financial Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Gilead Sciences, Inc. | S | 3,000 | $145.29 | 164,096 | Form 4 |
| 2026-09-10 | Gilead Sciences, Inc. | F | 1,347 | $144.81 | 167,096 | Form 4 |
| 2026-09-10 | Gilead Sciences, Inc. | M | 2,797 | — | 168,443 | Form 4 |
| 2026-08-17 | Gilead Sciences, Inc. | S | 3,000 | $138.36 | 165,646 | Form 4 |
| 2026-07-15 | Gilead Sciences, Inc. | S | 3,000 | $129.93 | 168,646 | Form 4 |
Questions
What stock did Dickinson Andrew D buy or sell?
Dickinson Andrew D reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($1.2M), across 1 company.
Is Dickinson Andrew D the same person as other filers with this name?
This page covers SEC CIK 1310204 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/dickinson-andrew-d-1310204.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.